Group 1: Market Performance - The overseas market experienced a year-on-year growth of 19.88% in 2024, achieving a revenue of 518 million [1] - The company has 16 years of experience in overseas market expansion, covering over 100 countries and regions [1] - The demand for digital equipment in the denture processing industry is slowing down in China, the US, and Europe, while the chairside market still holds significant potential [2] Group 2: Product Development and Sales - The company completed the acquisition of Korean Wolan in May 2024, with expected revenue of over 18 million in the second half of 2024 [2] - The narrow-neck implant and digital surgical tool kit from Wolan are expected to receive NMPA certification this year, with the ALL-ON-X occlusion reconstruction plan set to launch soon [3] - Sales of zirconia products are maintaining a medium to high growth rate, with stable prices and improved gross margins [6] Group 3: International Strategy and Risk Management - The European market accounts for the highest share of overseas revenue, followed by the Americas, with notable growth in the Middle East and Asia [4] - The US tariff policy has a controllable impact on the company's exports, with 38.15% of revenue coming from the domestic market, providing growth space and policy support [4] - The company plans to increase inventory at its US subsidiary to mitigate short-term impacts from tariffs [5] Group 4: Client Strategy and Market Expansion - In 2024, the company achieved significant results in large client cooperation, increasing the procurement budget share from major clients [6] - The company aims to build a global ecosystem of large and quality clients, promoting industry progress [6] - The company is enhancing brand building for Wolan and providing diverse training courses to strengthen market promotion [3] Group 5: Future Growth and Value Creation - The company expects stable growth in overseas business due to product quality, technological innovation, and customer service advantages [8] - The company focuses on core business development and technological innovation to enhance market competitiveness and profitability [9] - A stable cash dividend policy and improved investor relations management are part of the company's value realization strategy [9]
爱迪特(301580) - 301580爱迪特投资者关系管理信息20250429